Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
American Journal of Clinical Pathology
|
November 14, 2025
Hepatocellular adenomas with high-risk molecular alterations undetected by "high-risk" β-catenin and/or glutamine synthetase staining patterns
Hailey L Gosnell, Daniel E Roberts, Xuefeng Zhang, et al.
The American Journal of Surgical Pathology
|
December 29, 2023
Colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype
Umamaheshwari Golconda, Kelsey E McHugh, Daniela S Allende, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
Daniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Journal of Hepatology
|
November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma
Maria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
Virchows Archiv : an International Journal of Pathology
|
September 9, 2021
The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients
Vedha Sanghi, Carlos Romero-Marrero, Gianina Flocco, et al.
Cancer Immunology Research
|
August 24, 2019
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
Charles S Tannenbaum, Patricia A Rayman, Paul G Pavicic, et al.
Journal of Gastrointestinal Cancer
|
October 14, 2016
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes
Michael J McNamara, David J Adelstein, Daniela S Allende, et al.
Journal of Gastrointestinal Oncology
|
April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen
Michael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.
Journal of Hepatology
|
July 19, 2020
Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice
Han Wang, Hao Zhou, Quanri Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 28, 2017
Δ-5 Fatty Acid Desaturase <i>FADS1</i> Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators
Anthony D Gromovsky, Rebecca C Schugar, Amanda L Brown, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
American Journal of Clinical Pathology
|
November 14, 2025
Hepatocellular adenomas with high-risk molecular alterations undetected by "high-risk" β-catenin and/or glutamine synthetase staining patterns
Hailey L Gosnell, Daniel E Roberts, Xuefeng Zhang, et al.
The American Journal of Surgical Pathology
|
December 29, 2023
Colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype
Umamaheshwari Golconda, Kelsey E McHugh, Daniela S Allende, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
Daniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Journal of Hepatology
|
November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma
Maria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
Virchows Archiv : an International Journal of Pathology
|
September 9, 2021
The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients
Vedha Sanghi, Carlos Romero-Marrero, Gianina Flocco, et al.
Cancer Immunology Research
|
August 24, 2019
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
Charles S Tannenbaum, Patricia A Rayman, Paul G Pavicic, et al.
Journal of Gastrointestinal Cancer
|
October 14, 2016
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes
Michael J McNamara, David J Adelstein, Daniela S Allende, et al.
Journal of Gastrointestinal Oncology
|
April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen
Michael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.
Journal of Hepatology
|
July 19, 2020
Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice
Han Wang, Hao Zhou, Quanri Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 28, 2017
Δ-5 Fatty Acid Desaturase <i>FADS1</i> Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators
Anthony D Gromovsky, Rebecca C Schugar, Amanda L Brown, et al.
Page
of 8